In this session we review and discuss current, changing, and future legal and regulatory requirements applicable to telemedicine and the expansion of telemedicine. The session will include and focus on COVID-19 and Medicare reimbursement, licensure and prescribing issues, the fraud and abuse focus of the Office of Inspector General, and the continued emergence of telemedicine in clinical trials.

свернуть